Sign Up to like & get recommendations! 0
Published in 2021 at "Current Oncology Reports"
DOI: 10.1007/s11912-021-01133-8
Abstract: This review investigated the use of perioperative non-steroidal anti-inflammatory drugs (NSAIDs) and long-term outcomes in cancer surgery patients, and whether this is dependent on cancer type, type of NSAID and timing of administration. Perioperative NSAID… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Placenta"
DOI: 10.1016/j.placenta.2017.03.012
Abstract: Endoplasmic Reticulum Aminopeptidase 2 (ERAP2) trims HLA class I-binding peptides, determining the peptide repertoire presented for immune recognition. Variation in the ERAP2 amino acid sequence could affect the ability of some fetuses and tumors to… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "Thrombosis research"
DOI: 10.1016/j.thromres.2020.07.021
Abstract: INTRODUCTION Treatment of venous thromboembolism (VTE) in cancer patients with thrombocytopenia is challenging due to perceived higher risk of bleeding. MATERIAL AND METHODS We used the RIETE registry to compare the 10- and 30-day outcomes… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Nutrition and Cancer"
DOI: 10.1080/01635581.2022.2133151
Abstract: Abstract The outbreak of immunotherapy has revolutionized cancer treatment. Despite the results confirming the effectiveness of immunotherapy, some studies have reported poor responsiveness to this therapeutic approach. The effectiveness of immunotherapy is dependent on numerous… read more here.
Sign Up to like & get recommendations! 0
Published in 2023 at "Cancer investigation"
DOI: 10.1080/07357907.2023.2215325
Abstract: PURPOSE The cancer population is significantly impacted by coronavirus disease 2019 (COVID-19) due to inherent risks of infection imposed by malignancy and therapeutic agents. Evaluating risk factors in this group will lead to improved guidelines… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e18101
Abstract: e18101Background: Chemotherapy induced cardiomyopathy is an important complication of some chemotherapeutic agents. The stress of a cancer diagnosis and ongoing chemotherapy may contribute to cardi... read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.29_suppl.21
Abstract: 21Background: Cancer prevalence is rising and there is a corresponding increase in hospitalizations across the cancer continuum. However, little is known about the patterns of care and outcomes of ... read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2023.1144240
Abstract: Background Cancer and heart disease are the two most common health conditions in the world, associated with high morbidity and mortality, with even worse outcomes in regional areas. Cardiovascular disease is the leading cause of… read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "Cancers"
DOI: 10.3390/cancers14092209
Abstract: Simple Summary The spectrum of COVID-19 clinical presentation is wide and ranges from a mild flu-like illness to severe life-threatening respiratory illness with multiorgan involvement. The effects of the pandemic were particularly serious in patients… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "Cancers"
DOI: 10.3390/cancers17162609
Abstract: Simple Summary Clinical trial design relies on assumptions that may change over time, potentially affecting the accuracy of results. This study evaluates how deviations in design assumptions impact the statistical power of randomized trials with… read more here.